Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Opinion · 30 Sep 2021Exact title match Editorial · 24 Sep 2020Exact title match Cancer Biomarkers
Conference abstract · 2016Exact title match Cancer Biomarkers
Conference abstract · 26 Jun 2017 Glycosylated ribosomal protein S3, secreted from various cancer cells, is a possible cancer biomarker.
developing various antibodies against rpS3 which could be used as useful reagents for future cancer biomarkers. Image Fig 1. Cell Migration Assay for Invasive Cancer Cells References 1.Kim
Conference abstract · 21 Jul 2016 Immunomics using protein and peptide microarrays for (cancer) biomarker development
improve survival, thus there is a great need and anticipation to identify novel biomarkers for cancer diagnosis at the earliest possible stage, which can ideally be integrated in minimal-invasive ... clinical diagnosis…
Editorial · 30 Oct 2021 Biomarkers: Cancer Immunotherapy
Conference abstract · 30 Mar 2018 Expression of novel cancer biomarkers in ovarian cancer tissues and cells
MAPs are involved in the continuous assembly and disassembly of tubulin into
Article · 5 Apr 2022 Interleukin6 differential expression in cancer patients of different clinical stages a possible biomarker of cancer prog
Purpose: The study investigated Interleukin-6 expression pattern across all stages of
Conference abstract · 16 May 2018 Use of serum cancer biomarkers and prevalence of cancer in central Nepal: A tertiary care hospital-based study
normal or abnormal process or of a condition or disease. Large numbers of cancer biomarkers are used worldwide but limited number of serum cancer biomarkers are being used in Nepal ... this study was to find out the…
Conference abstract · 30 Aug 2016 EpCAM and claudins as cancer biomarkers in ovarian and colon cancer
The expressions of cell adhesion molecules (CAMs) that are located on the
Conference abstract · 2 Jul 2012 Bringing Biomarkers to Clinical Fruition: Prostate Cancer Biomarkers
biopsies. A panel of four candidate biomarkers showed sensitivity of 65.9% and specificity of 76% in identifying men with prostate cancer, ( Feb. 1 issue of Cancer Research). The four markers ... showing significant…
Editorial · 2012 Cancer Biomarkers: The Future Challenge of Cancer
cancer and creates the basis for the so called “personalized medicine”. However, this advancement has not been paralleled by discoveries in the field of biological indicators, or molecular biomarkers, able
Conference abstract · 2017 A new pan cancer biomarker, CA215 and its applications in cancer diagnostics
CA215 is a tumor-associated antigen with unique carbohydrate-associated epitope (ST
Research article · 2015 In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in Endometrial and Prostate Cancer Cell Lines
promote human wellness. This study aimed to investigate the effect of biofield treatment on cancer biomarkers involved in human endometrium and prostate cancer cell lines. Each cancer cell lines were ... treatment…
Conference abstract · 8 Dec 2014 The need of a computer aided program to correlate different breast cancer biomarkers in screening, diagnosis and prognosis of breast cancer
approximately 1.67 million new breast cancer cases diagnosed in 2012 (about 12% of all cancers). At the present time, there is a limited number of screening and early detection methods ... interleukin 2 (IL-2) levels…
Conference abstract · 14 May 2018 Optimizing Next-Generation Sequencing (NGS) and biomarkers in cancer clinical trials in Asia
created a growing interest among cancer specialists and pharmaceutical companies. Among all, using the adequate technology platform to identify the right genomic biomarker and provide treatment options is pivotal…
Conference abstract A potential universal cancer biomarker revealed by bioimaging of fluorescent probes for point-ofcare screening of cancer
disease but a complex progression of cellular/tissue mutation. Currently, no âÂ?Â?universalâÂ? cancer biomarker has been documented. It is a great challenge to find a universal cancer biomarker
Conference abstract · 3 Aug 2015 Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCC’s TNM staging system on overall survival of Caucasian females with breast cancer: An institution’s 10 year experience
outcomes in breast cancer because of the increasing understanding of prognostic impact of breast cancer biomarkers (ER/PR/HER2). Inclusion of biomarkers into the TNM system (bTNM) with goal ... traditional TNM staging…
Brief report · 29 Dec 2025 Validating Cancer Biomarkers: Challenges and Precision Medicine
Article · 26 Dec 2025 Immunochemical Approaches in Cancer Biomarker Detection
Conference abstract · 27 Oct 2025 Screen-printed nanocomposite immunosensor for multiplexed detection of bladder cancer biomarkers at the point-of-care
Bladder cancer (BC) is a major global health challenge, with early detection and monitoring heavily reliant on invasive cystoscopy due to the shortcomings of existing point-of-care (POC) diagnostic ... tools. Current…
Short communication · 30 Jun 2025 Cancer Biomarkers: Emerging Tools for Early Detection, Prognosis, and Precision Oncology
mortality worldwide, largely due to late-stage diagnosis, tumor heterogeneity, and therapeutic resistance. Cancer biomarkers have emerged as indispensable tools in modern oncology, enabling early detection, prognosis…
Brief report · 30 May 2025 Revolutionizing Cancer: Biomarkers, AI, Resistance
Brief report · 30 May 2025 Advancing Cancer Biomarkers: Detection to Therapy
Research article · 27 Apr 2025 The Intersection of Cancer Biomarkers and Superficial Acral Fibromyxoma: A Review of Literature for Pathologists and Dermatologists
Introduction: Superficial Acral Fibromyxoma (SAF) is a benign fibromyxoid tumor that presents
Perspective · 28 Mar 2025 Non-coding RNAs in Cancer: Biomarkers and Therapeutic Targets
Opinion · 30 Dec 2024 Portable Amperometric Biosensor Improved with Enzyme-based Ternary Nanocomposites for Detecting Prostate Cancer Biomarkers
nanocomposites into these biosensors represents a groundbreaking advancement, offering enhanced detection capabilities for prostate cancer biomarkers. This discussion explores the principles, design, and advantages of…

